Wallenberg Clinical Scholars 2017

The Knut and Alice Wallenberg Foundation is investing almost SEK 600 million over a ten-year period in the research programme Wallenberg Clinical Scholars. The programme provides funding for 25 of the country’s foremost clinical researchers.

The aim of the programme is to strengthen Swedish clinical research by means of identifying the best clinical researchers, providing them with good conditions to undertake their work, and facilitate the impact of research results in the scientific and healthcare communities.

Wallenberg Clinical Scholars is part of a ten-year initiative amounting to a total of SEK 1.7 billion, undertaken by the Knut and Alice Wallenberg Foundation to strengthen medical research and the life sciences.

Wallenberg Clinical Scholars 2017

Birgitta Henriques Normark, head physician and professor at the Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet

She will investigate why rare types of pneumococci are prone to spread and cause disease and become resistant to antibiotics. The aim is to prevent severe and fatal infections. 

Combatting pneumococcal infections

Richard Rosenquist Brandell, chief physician and professor at the Department of Immunology, Genetics and Pathology, Uppsala University

He will study the properties of blood cancer cells in the finest molecular detail to better understand the different faces of the chronic lymphocytic leukemia disease and to find more effective treatments.

Refining our understanding of leukemia

Earlier years